Study of the Effect of Water Soluble Oral Contrast (Gastrografin) on Postoperative Ileus After Colorectal Surgery
Information source: Hospital Universitari de Bellvitge
Information obtained from ClinicalTrials.gov on February 07, 2013 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Postoperative Ileus
Intervention: Gastrografin (Drug); physiological serum (Drug)
Phase: Phase 4
Status: Recruiting
Sponsored by: Hospital Universitari de Bellvitge Official(s) and/or principal investigator(s): Sebastiano Biondo, Dr., Principal Investigator, Affiliation: Bellvitge University Hospital
Overall contact: Sebastiano Biondo, Dr., Phone: 0034 93 260 75 23, Email: sbiondo@bellvitgehospital.cat
Summary
The purpose of this trial is to determine whether the water-soluble contrast (gastrografin)
is more effective in the treatment of postoperative ileus than the conventional one.
Clinical Details
Official title: Prospective Randomized Double Blind Study of the Effect of Gastrografin on Postoperative Ileus After Colorectal Surgery
Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment
Primary outcome: Time to resolution of postoperative ileus after surgery defined as time to tolerance of oral intake of solid or semisolid food
Secondary outcome: Hospital stay after diagnosis of ileusPercentage of patients requiring total parenteral nutrition. Presence of postoperative pain and analgesic required Percentage of mortality during hospitalization.
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- All patients with postoperative ileus after colorectal surgery, defined as the
presence from the third postoperative day, abdominal distension, nausea, vomiting
with or without abdominal pain or discomfort by dilation of bowel loops, confirmed
radiology of the abdomen, and which are: Age > 18 years Patients undergoing
laparotomy or laparoscopy for the following variants of colorectal disease with or
without stoma:
1. Neoplasia.
2. Inflammatory disease.
3. Diverticular disease. Patients who have been treated with standard PCA as
postoperative analgesia. Signed informed consent. Undergoing elective or
scheduled
Exclusion Criteria:
- Patient's refusal to sign informed consent
- Pregnancy or lactation
- Hypersensitivity to iodinated contrast agents (it´s the only contraindication to oral
Gastrografin) Presence of other problems that justify the etiology of postoperative
ileus:
1. Anastomotic leakages.
2. Mesenteric vascular disease.
3. Incarcerated hernias.
4. Intra-abdominal abscesses or collections.
5. Metabolic or electrolyte disturbances. If during the course of the study one of
the reasons previously cited as the etiology of postoperative ileus is present,
the patient shall also be excluded. Also excluded patients undergoing emergency
surgery.
Locations and Contacts
Sebastiano Biondo, Dr., Phone: 0034 93 260 75 23, Email: sbiondo@bellvitgehospital.cat
Bellvitge University Hospital, L´Hospitalet de Llobregat, Barcelona 08907, Spain; Recruiting Sebastiano Biondo, Dr., Phone: 0034 93 260 75 23, Email: sbiondo@bellvitgehospital.cat Sebastiano Biondo, Dr., Principal Investigator
Bellvitge University Hospital, L´Hospitalet de Llobregat, Barcelona 08907, Spain; Not yet recruiting Sebastiano Biondo, Dr., Phone: 0034 93 260 75 23, Email: sbiondo@bellvitgehospital.cat Sebastiano Biondo, Dr., Principal Investigator
Additional Information
Related publications: Chen JH, Hsieh CB, Chao PC, Liu HD, Chen CJ, Liu YC, Yu JC. Effect of water-soluble contrast in colorectal surgery: a prospective randomized trial. World J Gastroenterol. 2005 May 14;11(18):2802-5. Biondo S, Parés D, Mora L, Martí Ragué J, Kreisler E, Jaurrieta E. Randomized clinical study of Gastrografin administration in patients with adhesive small bowel obstruction. Br J Surg. 2003 May;90(5):542-6. Abbas SM, Bissett IP, Parry BR. Meta-analysis of oral water-soluble contrast agent in the management of adhesive small bowel obstruction. Br J Surg. 2007 Apr;94(4):404-11. Review. Delaney CP, Wolff BG, Viscusi ER, Senagore AJ, Fort JG, Du W, Techner L, Wallin B. Alvimopan, for postoperative ileus following bowel resection: a pooled analysis of phase III studies. Ann Surg. 2007 Mar;245(3):355-63. Waldhausen JH, Schirmer BD. The effect of ambulation on recovery from postoperative ileus. Ann Surg. 1990 Dec;212(6):671-7. Böhm B, Milsom JW, Fazio VW. Postoperative intestinal motility following conventional and laparoscopic intestinal surgery. Arch Surg. 1995 Apr;130(4):415-9. Holte K, Kehlet H. Postoperative ileus: a preventable event. Br J Surg. 2000 Nov;87(11):1480-93. Review.
Starting date: December 2011
Last updated: June 10, 2012
|